删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Human germline editing: Insights to future clinical treatment of diseases

本站小编 Free考研考试/2022-01-02

Yanni Li1,
Xiang Jin Kang1,
Jeremy Kah Sheng Pang2,
Boon Seng Soh1,2,
Yang Yu3,,
Yong Fan1,
1 Key Laboratory for Major Obstetric Diseases of Guangdong Province, Center of Reproductive Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China;
2 Disease Modeling and Therapeutics Laboratory, A*STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore;
3 Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
Funds: This work was supported by the National Key R&D Program of China (2016YFC1000601), National Natural Science Foundation of China (Grant Nos. 81570101, 81728002, 81741006 and 81871162), Guangdong Province Science and Technology Project (2017A020214005) and the Guangzhou Science and Technology Project (201803010048).






Abstract



PDF全文下载地址:

http://www.protein-cell.org/article/exportPdf?id=6dadf233-5855-4b34-b95c-3378b936f654&language=en
相关话题/Human germline editing